// App-Quantinova.ai

TCT-474 : Paclitaxel-eluting Balloon In Primary Percutaneous Coronary Intervention In Amsterdam (PAPPA): Sustained Safety And Efficacy At 12 Months Follow-up

Researchers

Presenter

  • Nicola Vos

Principal Investigators

  • Maurits Dirksen

  • Ferdinand Van Nooijen

  • Ton Slagboom

  • Giovanni Amoroso

  • Ferdinand Kiemeneij

  • Mark Patterson

  • Jean-Paul Herrman

  • Rene Van der Schaaf

Medical Centers

  • Onze Lieve Vrouwe Gasthuis, Amsterdam, Noord-Holland, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Bivalirudin

  • Paclitaxel

  • Prasugrel

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved